Upgrade to SI Premium - Free Trial

Medicines Co. (MDCO) Updtes on ORION-1 Study; Says IDMC Raised No Safety Concerns

October 5, 2016 4:37 PM
The Medicines Company (Nasdaq: MDCO) provided a progress update on the ongoing ORION-1 study of PCSK9si, its investigational first-in-class PCSK9 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles